Chemotherapy in advanced gastric cancer: a systematic review and meta-analysis based on aggregate data

AD Wagner, W Grothe, J Haerting, G Kleber… - Journal of clinical …, 2006 - ascopubs.org
Purpose This systematic review and meta-analysis were performed to assess the efficacy
and tolerability of chemotherapy in patients with advanced gastric cancer. Methods …

Surgical resection of hepatic metastases from colorectal cancer: a systematic review of published studies

PC Simmonds, JN Primrose, JL Colquitt… - British journal of …, 2006 - nature.com
No consensus on the indications for surgical resection of colorectal liver metastases exists.
This systematic review has been undertaken to assess the published evidence for its …

Bevacizumab: an angiogenesis inhibitor for the treatment of solid malignancies

T Shih, C Lindley - Clinical therapeutics, 2006 - Elsevier
BACKGROUND:: Bevacizumab is a recombinant humanized monoclonal antibody that was
approved by the US Food and Drug Administration (FDA) in February 2004 for use as part of …

Multicenter randomized trial of adjuvant fluorouracil and folinic acid compared with surgery alone after resection of colorectal liver metastases: FFCD ACHBTH AURC …

G Portier, D Elias, O Bouche, P Rougier… - Journal of Clinical …, 2006 - ascopubs.org
Purpose Complete resection of liver metastases of colorectal origin is the only potentially
curative treatment. In order to decrease recurrences, the use of adjuvant systemic …

FOLFOXIRI (folinic acid, 5-fluorouracil, oxaliplatin and irinotecan) vs FOLFIRI (folinic acid, 5-fluorouracil and irinotecan) as first-line treatment in metastatic colorectal …

J Souglakos, N Androulakis, K Syrigos… - British journal of …, 2006 - nature.com
To compare the efficacy and toxicity of oxaliplatin (L-OHP) in combination with irinotecan
(CPT-11), 5-fluorouracil (5-FU) and leucovorin (LV)(FOLFOXIRI) vs irinotecan and 5-FU/LV …

Hepatic arterial infusion versus systemic therapy for hepatic metastases from colorectal cancer: a randomized trial of efficacy, quality of life, and molecular markers …

NE Kemeny, D Niedzwiecki, DR Hollis… - Journal of Clinical …, 2006 - ascopubs.org
Purpose Hepatic metastases derive most of their blood supply from the hepatic artery;
therefore, for patients with hepatic metastases from colorectal cancer, hepatic arterial …

Resin 90Y-microsphere brachytherapy for unresectable colorectal liver metastases: modern USA experience

AS Kennedy, D Coldwell, C Nutting, R Murthy… - International Journal of …, 2006 - Elsevier
Purpose: Salvage therapy for patients with unresectable colorectal liver metastases that
were refractory to oxaliplatin and irinotecan was performed via radioactive microspheres …

Phase III trial comparing 4-day chronomodulated therapy versus 2-day conventional delivery of fluorouracil, leucovorin, and oxaliplatin as first-line chemotherapy of …

S Giacchetti, G Bjarnason, C Garufi, D Genet… - Journal of clinical …, 2006 - ascopubs.org
Purpose In two previous randomized trials, the adjustment of chemotherapy delivery to
circadian rhythms improved tolerability and anticancer activity compared with constant-rate …

Treatment with 5-fluorouracil/folinic acid, oxaliplatin, and irinotecan enables surgical resection of metastases in patients with initially unresectable metastatic colorectal …

G Masi, S Cupini, L Marcucci, E Cerri… - Annals of surgical …, 2006 - Springer
Background The prognosis of unresectable metastatic colorectal cancer might be improved
if a radical surgical resection of metastases could be performed after a response to …

Long-term outcome of radiofrequency ablation for unresectable liver metastases from colorectal cancer: evaluation of prognostic factors and effectiveness in first-and …

J Machi, AJ Oishi, K Sumida, K Sakamoto… - The Cancer …, 2006 - journals.lww.com
PURPOSE Long-term follow-up data of radiofrequency ablation (RFA) for patients with
unresectable metastatic liver tumors from colorectal cancer have rarely been reported. This …